SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 90 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $86,000 | – | 10,270 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
| Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
| Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
| AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
| Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
| Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |